Eupraxia Pharmaceuticals ... (EPRX)
NASDAQ: EPRX
· Real-Time Price · USD
5.32
0.04 (0.76%)
At close: Aug 15, 2025, 3:49 PM
5.30
-0.43%
After-hours: Aug 15, 2025, 04:55 PM EDT
Eupraxia Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -26.35M | -27.74M | -24.56M | -30.14M | -31.9M | -28.71M | -33.44M | -26.67M | -25.12M | -23.92M | -18.61M | -18.95M | -18.27M | -23.37M | -19.73M | -15.32M | -10.72M |
Depreciation & Amortization | 196.27K | 200.24K | 153.55K | 165.69K | 157.37K | 155.53K | 202.83K | 202.81K | 202.53K | 193.27K | 179.56K | 159.24K | 130.66K | 111.53K | 92.3K | 83.69K | 85.1K |
Stock-Based Compensation | 4.5M | 3.22M | 2.52M | 2.49M | 1.7M | 1.8M | 2.44M | 2.12M | 1.71M | 1.91M | 1.5M | 1.77M | 2.03M | 4.21M | 3.73M | 3.36M | 2.89M |
Other Working Capital | -8.42M | -7.41M | -7.28M | -2.13M | 1.98M | -231.24K | 1.76M | 63.45K | 869.81K | 1.76M | -569.14K | 2.85M | 798.94K | 1.8M | 2.14M | n/a | n/a |
Other Non-Cash Items | -3.33M | -3.67M | -3.65M | -3.68M | 326.21K | 1.48M | 2.02M | 2.25M | 1.64M | 1.16M | 940.86K | 870.87K | 1.2M | 4.57M | 4.78M | 4.54M | 4.32M |
Deferred Income Tax | n/a | n/a | -1.96M | 778.21K | 728.16K | 633.15K | 2.63M | -403.95K | -467.2K | -305.15K | -303.4K | -176.62K | -1.82K | 1.2M | 1.1M | 1.23M | 1.24M |
Change in Working Capital | -7.72M | -6.68M | -7.24M | -2.11M | 2.03M | -203.67K | 2.06M | 371.96K | 1.19M | 2.07M | -857.37K | 2.51M | 649.89K | -211.43K | -72.19K | -1.72M | -1.86M |
Operating Cash Flow | -32.7M | -34.95M | -35.1M | -32.85M | -28.01M | -25.92M | -25.09M | -23.02M | -21.06M | -18.78M | -17.04M | -13.64M | -14.15M | -14.64M | -11.2M | -9.06M | -5.28M |
Capital Expenditures | -266.48K | -106.59K | -111.97K | -82.45K | -80.15K | -81.89K | -117.41K | -155.43K | -312.49K | -308.37K | -241.23K | -598.93K | -434.65K | -431.67K | -413.6K | -5.13K | -3.8K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 310.00 | 310.00 | 310.00 | 310.00 | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | 18M | 18M | n/a | n/a | -27M | -27M | -9M | -9M | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | 50.38K | 50.38K | 9.06M | 9.06M | 9.01M | 9.01M | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 29.07K | 29.07K | 28.51K | 28.51K | n/a | n/a | 22.63K | 22.63K | 22.63K | 22.63K | -9M | -8.95M | -8.95M | -14.02M | -5.02M | -5.06M | -5.06M |
Investing Cash Flow | -237.41K | -77.53K | -74.95K | -45.43K | -71.64K | -73.38K | 17.88M | 17.84M | 8.7M | 8.7M | -18.23M | -18.54M | -9.39M | -14.45M | -5.44M | -5.07M | -5.02M |
Debt Repayment | -9.1M | -9.13M | -9.17M | -4.59M | -118.49K | -126.4K | -88.89K | -62.07K | -59.05K | -59.6K | -137.73K | 283.34K | 9.59M | 11.63M | 11.7M | 11.28M | 2M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 217.88K | -233.98K | -119.05K | -6.13M | -5.92M | -5.6M | -5.79M | 182.04K | 182.04K | -125.58K | -104.07K | -79.19K | -620.31K | -8.48M | -8.62M | -8.6M | -7.45M |
Financial Cash Flow | 23.06M | 53.86M | 22.31M | 48.95M | 59.46M | 28.5M | 28.67M | 6.59M | 13.83M | 13.52M | 13.01M | 13.46M | 9.46M | 49.92M | 49.89M | 49.49M | 40.82M |
Net Cash Flow | -8.45M | 12.58M | -16.95M | 11.81M | 24.65M | 3.38M | 21.41M | 1.7M | 1.97M | 3.84M | -21.86M | -18.68M | -14.24M | 20.74M | 33.24M | 35.3M | 30.51M |
Free Cash Flow | -30.14M | -32.23M | -32.38M | -30.11M | -28.09M | -26M | -25.21M | -23.18M | -21.37M | -19.08M | -17.28M | -14.24M | -14.59M | -15.07M | -11.61M | -9.07M | -5.29M |